• NEW

Metabolic Disease State

iCan i3
The first 15-day Continuous Glucose Monitoring (CGM) device, iCan i3, is the latest choice in diabetes management. iCan i3 is the newest product from Sinocare designed to detect trends, track patterns, aid in identifying episodes of hyperglycemia and hypoglycemia, and facilitate easy real-time adjustments to acute and long-term therapy in diabetic patients; without finger pricks, scans, or calibrations. iCan i3 can be used alongside an application, allowing users to manually control therapy decisions.